Loading…
Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels
Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid) A receptor channels (α 1β 2γ 2-subunits) and glycine receptor channels (α 1β-subunits) transiently expressed in HEK293 cells. For electrophys...
Saved in:
Published in: | European journal of pharmacology 2001-03, Vol.415 (2), p.135-140 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 140 |
container_issue | 2 |
container_start_page | 135 |
container_title | European journal of pharmacology |
container_volume | 415 |
creator | Mohammadi, Bahram Krampfl, Klaus Moschref, Hafis Dengler, Reinhard Bufler, Johannes |
description | Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid)
A receptor channels (α
1β
2γ
2-subunits) and glycine receptor channels (α
1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α
1β
2γ
2 GABA
A receptor channels or α
1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions. |
doi_str_mv | 10.1016/S0014-2999(01)00847-0 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_77006104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014299901008470</els_id><sourcerecordid>77006104</sourcerecordid><originalsourceid>FETCH-LOGICAL-e195t-62bb1a891a9352019cea9858947923caabdaa8b8bd745f61f29cb404388911b93</originalsourceid><addsrcrecordid>eNo9kE1PwkAQhjdGI4j-BM2ejB6qM_2g3ZOpRJGExIN68bLZbgdYU7a43WLw11sQPU0yed7JOw9j5wg3CDi8fQHAOAiFEFeA1wBZnAZwwPqYpSKAFMND1v9HeuykaT4AIBFhcsx6iGEaC4F99j6xnpzS3tSW1zPuF8Qtta5eudpTt14TL107585U7XddEf8yfsHH-X3Oc65syefVRhtL3JGmla8d1wtlLVXNKTuaqaqhs_0csLfHh9fRUzB9Hk9G-TQgFIkPhmFRoMoEKhElIaDQpESWZCJORRhppYpSqazIijKNk9kQZ6HQRQxxlHUZLEQ0YJe_d7vKny01Xi5No6mqlKW6bWSaAgyxCwzYxR5siyWVcuXMUrmN_LPRAXe_QNee1oacbLQhq6k03XdelrWRCHLrX-78y61cCSh3_iVEP9EydnY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77006104</pqid></control><display><type>article</type><title>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Mohammadi, Bahram ; Krampfl, Klaus ; Moschref, Hafis ; Dengler, Reinhard ; Bufler, Johannes</creator><creatorcontrib>Mohammadi, Bahram ; Krampfl, Klaus ; Moschref, Hafis ; Dengler, Reinhard ; Bufler, Johannes</creatorcontrib><description>Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid)
A receptor channels (α
1β
2γ
2-subunits) and glycine receptor channels (α
1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α
1β
2γ
2 GABA
A receptor channels or α
1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/S0014-2999(01)00847-0</identifier><identifier>PMID: 11274991</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Cell Line ; Dose-Response Relationship, Drug ; GABA A receptor channel ; gamma-Aminobutyric Acid - pharmacology ; Glycine - pharmacology ; Glycine receptor channel ; Humans ; Kidney - cytology ; Neuroprotective Agents - pharmacology ; Patch-Clamp Techniques ; Patch–clamp technique ; Rapid application ; Receptors, GABA-A - drug effects ; Receptors, GABA-A - physiology ; Receptors, Glycine - drug effects ; Receptors, Glycine - physiology ; recombinant α 1β ; recombinant α 1β 2γ 2 ; Riluzole ; Riluzole - pharmacology</subject><ispartof>European journal of pharmacology, 2001-03, Vol.415 (2), p.135-140</ispartof><rights>2001 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11274991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohammadi, Bahram</creatorcontrib><creatorcontrib>Krampfl, Klaus</creatorcontrib><creatorcontrib>Moschref, Hafis</creatorcontrib><creatorcontrib>Dengler, Reinhard</creatorcontrib><creatorcontrib>Bufler, Johannes</creatorcontrib><title>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</title><title>European journal of pharmacology</title><addtitle>Eur J Pharmacol</addtitle><description>Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid)
A receptor channels (α
1β
2γ
2-subunits) and glycine receptor channels (α
1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α
1β
2γ
2 GABA
A receptor channels or α
1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.</description><subject>Cell Line</subject><subject>Dose-Response Relationship, Drug</subject><subject>GABA A receptor channel</subject><subject>gamma-Aminobutyric Acid - pharmacology</subject><subject>Glycine - pharmacology</subject><subject>Glycine receptor channel</subject><subject>Humans</subject><subject>Kidney - cytology</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Patch-Clamp Techniques</subject><subject>Patch–clamp technique</subject><subject>Rapid application</subject><subject>Receptors, GABA-A - drug effects</subject><subject>Receptors, GABA-A - physiology</subject><subject>Receptors, Glycine - drug effects</subject><subject>Receptors, Glycine - physiology</subject><subject>recombinant α 1β</subject><subject>recombinant α 1β 2γ 2</subject><subject>Riluzole</subject><subject>Riluzole - pharmacology</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNo9kE1PwkAQhjdGI4j-BM2ejB6qM_2g3ZOpRJGExIN68bLZbgdYU7a43WLw11sQPU0yed7JOw9j5wg3CDi8fQHAOAiFEFeA1wBZnAZwwPqYpSKAFMND1v9HeuykaT4AIBFhcsx6iGEaC4F99j6xnpzS3tSW1zPuF8Qtta5eudpTt14TL107585U7XddEf8yfsHH-X3Oc65syefVRhtL3JGmla8d1wtlLVXNKTuaqaqhs_0csLfHh9fRUzB9Hk9G-TQgFIkPhmFRoMoEKhElIaDQpESWZCJORRhppYpSqazIijKNk9kQZ6HQRQxxlHUZLEQ0YJe_d7vKny01Xi5No6mqlKW6bWSaAgyxCwzYxR5siyWVcuXMUrmN_LPRAXe_QNee1oacbLQhq6k03XdelrWRCHLrX-78y61cCSh3_iVEP9EydnY</recordid><startdate>200103</startdate><enddate>200103</enddate><creator>Mohammadi, Bahram</creator><creator>Krampfl, Klaus</creator><creator>Moschref, Hafis</creator><creator>Dengler, Reinhard</creator><creator>Bufler, Johannes</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200103</creationdate><title>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</title><author>Mohammadi, Bahram ; Krampfl, Klaus ; Moschref, Hafis ; Dengler, Reinhard ; Bufler, Johannes</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e195t-62bb1a891a9352019cea9858947923caabdaa8b8bd745f61f29cb404388911b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Cell Line</topic><topic>Dose-Response Relationship, Drug</topic><topic>GABA A receptor channel</topic><topic>gamma-Aminobutyric Acid - pharmacology</topic><topic>Glycine - pharmacology</topic><topic>Glycine receptor channel</topic><topic>Humans</topic><topic>Kidney - cytology</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Patch-Clamp Techniques</topic><topic>Patch–clamp technique</topic><topic>Rapid application</topic><topic>Receptors, GABA-A - drug effects</topic><topic>Receptors, GABA-A - physiology</topic><topic>Receptors, Glycine - drug effects</topic><topic>Receptors, Glycine - physiology</topic><topic>recombinant α 1β</topic><topic>recombinant α 1β 2γ 2</topic><topic>Riluzole</topic><topic>Riluzole - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohammadi, Bahram</creatorcontrib><creatorcontrib>Krampfl, Klaus</creatorcontrib><creatorcontrib>Moschref, Hafis</creatorcontrib><creatorcontrib>Dengler, Reinhard</creatorcontrib><creatorcontrib>Bufler, Johannes</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohammadi, Bahram</au><au>Krampfl, Klaus</au><au>Moschref, Hafis</au><au>Dengler, Reinhard</au><au>Bufler, Johannes</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels</atitle><jtitle>European journal of pharmacology</jtitle><addtitle>Eur J Pharmacol</addtitle><date>2001-03</date><risdate>2001</risdate><volume>415</volume><issue>2</issue><spage>135</spage><epage>140</epage><pages>135-140</pages><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>Riluzole is used as therapeutic agent in amyotrophic lateral slerosis. We investigated the interaction of riluzole with recombinant GABA (γ-aminobutyric acid)
A receptor channels (α
1β
2γ
2-subunits) and glycine receptor channels (α
1β-subunits) transiently expressed in HEK293 cells. For electrophysiological experiments, the patch–clamp technique in combination with tools for ultrafast solution exchange was used. Saturating concentrations of GABA or glycine were applied with different concentrations of riluzole to outside-out patches containing α
1β
2γ
2 GABA
A receptor channels or α
1β-glycine receptor channels on their surface, respectively. The current declined after application of GABA or glycine with three time constants of desensitization to a steady-state current amplitude. Application of riluzole resulted in a shift to fast desensitized states at both receptors. The proportion of the time constants of fast desensitization increased and the time constants of slow desensitization and the steady-state current decreased whereas the maximal current amplitudes were not affected by riluzole. The data of the study demonstrate for the first time interaction of GABAergic and glycinergic currents with riluzole under physiological conditions.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>11274991</pmid><doi>10.1016/S0014-2999(01)00847-0</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2001-03, Vol.415 (2), p.135-140 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_77006104 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Cell Line Dose-Response Relationship, Drug GABA A receptor channel gamma-Aminobutyric Acid - pharmacology Glycine - pharmacology Glycine receptor channel Humans Kidney - cytology Neuroprotective Agents - pharmacology Patch-Clamp Techniques Patch–clamp technique Rapid application Receptors, GABA-A - drug effects Receptors, GABA-A - physiology Receptors, Glycine - drug effects Receptors, Glycine - physiology recombinant α 1β recombinant α 1β 2γ 2 Riluzole Riluzole - pharmacology |
title | Interaction of the neuroprotective drug riluzole with GABA A and glycine receptor channels |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T09%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interaction%20of%20the%20neuroprotective%20drug%20riluzole%20with%20GABA%20A%20and%20glycine%20receptor%20channels&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Mohammadi,%20Bahram&rft.date=2001-03&rft.volume=415&rft.issue=2&rft.spage=135&rft.epage=140&rft.pages=135-140&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/S0014-2999(01)00847-0&rft_dat=%3Cproquest_pubme%3E77006104%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e195t-62bb1a891a9352019cea9858947923caabdaa8b8bd745f61f29cb404388911b93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77006104&rft_id=info:pmid/11274991&rfr_iscdi=true |